MADAX
Price
$26.70
Change
+$0.05 (+0.19%)
Updated
Jul 25 closing price
Net Assets
119.55M
VIVIX
Price
$70.44
Change
+$0.29 (+0.41%)
Updated
Jul 25 closing price
Net Assets
195.18B
Interact to see
Advertisement

MADAX vs VIVIX

Header iconMADAX vs VIVIX Comparison
Open Charts MADAX vs VIVIXBanner chart's image
Madison Dividend Income A
Price$26.70
Change+$0.05 (+0.19%)
VolumeN/A
Net Assets119.55M
Vanguard Value Index I
Price$70.44
Change+$0.29 (+0.41%)
VolumeN/A
Net Assets195.18B
MADAX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MADAX vs. VIVIX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MADAX is a Buy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 195B vs. MADAX (120M). VIVIX pays higher dividends than MADAX: VIVIX (2.19) vs MADAX (1.60). MADAX was incepted earlier than VIVIX: MADAX (5 years) vs VIVIX (27 years). MADAX (1.16) is less costly to investors than VIVIX (0.04). MADAX is a more actively managed with annual turnover of: 28.00 vs. VIVIX (9.00). MADAX has a lower initial minimum investment than VIVIX: MADAX (1000) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 9.30 vs. MADAX (-0.42). VIVIX return over 5 years is better than : 74.15 vs. MADAX (11.05).
MADAXVIVIXMADAX / VIVIX
Total Expense Ratio1.160.042,900%
Annual Report Gross Expense Ratio1.160.042,900%
Fund Existence5 years27 years-
Gain YTD6.2096.29099%
Front Load6%N/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets120M195B0%
Annual Yield % from dividends1.602.1973%
Returns for 1 year-0.429.30-4%
Returns for 3 years-2.8933.77-9%
Returns for 5 years11.0574.1515%
Returns for 10 yearsN/A115.37-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLAY3.740.06
+1.63%
Relay Therapeutics
INCR1.550.01
+0.65%
Intercure Ltd
EXPD116.70-0.14
-0.12%
Expeditors International of Washington
XIFR9.52-0.07
-0.73%
XPLR Infrastructure LP
NLSP1.98-0.18
-8.33%
Nls Pharmaceutics Ltd